Environmental

TGTX’s R&D intensity is high versus diversified biopharma peers, supporting lower-waste innovation but also sustaining a resource-intensive operating model.

The company’s capital allocation is more research-heavy than commercial-stage peers, which can improve pipeline sustainability while limiting near-term environmental efficiency gains.

No direct emissions, energy, or water disclosures were provided, so environmental positioning is assessed mainly through R&D and operating intensity relative to peers.

Compared with larger peers that disclose broader decarbonization programs, TGTX appears less transparent on environmental management, which weakens comparability rather than indicating clear underperformance.

Social

TGTX’s elevated R&D spend relative to revenue suggests a workforce and scientific model centered on innovation, which is typically stronger on talent attraction than peers with lower research intensity.

Stock-based compensation remains meaningful versus revenue, aligning employee incentives with long-term development milestones and supporting retention relative to smaller biotech peers.

As a biotech developer, TGTX’s social materiality is driven more by patient access, trial integrity, and scientific quality than by labor intensity, and no adverse disclosures were provided.

Relative to peers, the absence of reported labor or clinical controversy supports a stronger social profile, although limited disclosure reduces confidence versus best-in-class companies.

Governance

TGTX’s debt-to-equity and net debt-to-EBITDA ratios indicate moderate leverage for a biotech issuer, which can constrain governance flexibility versus peers with cleaner balance sheets.

Stock-based compensation at 12.6% of revenue is material, so governance quality depends on whether dilution is tightly controlled relative to peer compensation practices.

High gross margin supports operational discipline, but it does not offset the need for strong oversight of capital allocation, especially in a research-driven business.

Compared with stronger-governed peers that provide more detailed risk oversight and incentive disclosure, TGTX appears adequate but not distinguished on governance transparency.

Overall Score

TGTX’s ESG profile is moderate versus peers, with its strongest relative position in social factors and its main limitation in governance transparency and leverage.

Score Driver: Limited Disclosure And Moderate Leverage Temper Otherwise Solid Research-Driven Social Positioning.